Sandra Weiss, M.D., FACC

Our Experts

Back to all Experts
Sandra Weiss, M.D., FACC

Sandra Weiss, M.D., FACC

Interventional Cardiologist, Medical Director CardiacIntensive Care Unit

Expertise & Research Interests

  • General Cardiology
  • Interventional Cardiology
  • Peripheral Vascular Intervention
  • Cardiac Hemodynamics and Shock
  • Mechanical Circulatory Support


  • B.S., Northwestern University
  • M.D., University of Chicago Pritzker School of Medicine

Sandra Weiss, M.D., FACC

Interventional Cardiologist, Medical Director CardiacIntensive Care Unit

Dr. Weiss is an active member of the Interventional Cardiology staff at ChristianaCare, with a special interest in both coronary and peripheral interventions. She was integral in the implementation and development of radial artery catheterization, a procedure which is known to reduce complications and improve patient satisfaction and survival during coronary interventional procedures.


of 09


Downloadable Images and Links
Media Appearances

Bystander Rescue Breathing CPR in Kids Tied to Better Survival

2021-08-30 , Medscape
Sandra Weiss, MD, an interventional cardiologist and the medical director of the cardiac intensive care unit at ChristinaCare..
Selected Papers and Publications

Exercise Blood Pressure and Future Cardiovascular Death in Asymptomatic Individuals

2010-05-03 , Circulation
Individuals with exaggerated exercise blood pressure (BP) tend to develop future hypertension. It is controversial whether they have higher risk of death from cardiovascular disease (CVD).

Long-term use of dual antiplatelets for the secondary prevention of atherothrombotic events in patients with and without mi: meta-analysis of randomized controlled trials

Journal of American College of Cardiology
The potential benefit of long-term dual antiplatelet therapy (DAPT) for secondary prevention of atherothrombotic events is unclear. Data from different randomized controlled trials (RCT) using different agents in different subgroups showed inconsistent results.

Academic Versus Private Cardiology: Preparing for Successful Career after Fellowship

Journal of the American College of Cardiology
Cardiovascular diseases are still considered the leading cause of death in the United States. It is estimated that 40% of Americans will experience some form of cardiovascular disease by 2030.

Revascularization vs. Medical Therapy in Stable Ischemic Heart Disease

Progress in Cardiovascular Diseases
The keynote COURAGE and BARI-2D trials changed the way the interventional community selects patients for revascularization. What we now consider appropriate, especially for percutaneous coronary intervention, has narrowed significantly in scope compared to previous practice a decade ago.

Clinical Trials Versus Clinical Practice: When Evidence and Practice Diverge--Should Nondiabetic Patients With 3-Vessel Disease and Stable Ischemic Heart Disease Be Preferentially Treated With CABG?

JACC: Cardiovascular Interventions
The planning of revascularization strategy for multivessel coronary artery disease (CAD) in nondiabetic patients is optimally made through considering the goals of improving survival and/or relieving symptoms.
External Service and Affiliations
  • American College of Cardiology : Fellow
Selected Honors and Awards
  • American Medical Women's Association Award, Received from the University of Chicago in 2004.
  • ChristianaCare Internal Medicine Residence Clinical Peals Award, ChristianaCare Internal Medicine Residency Clinical Pearls Award 2020.
  • MD Distinguished Educator Award, ChristianaCare Department of Medicine Virginia U. Collier, MD Distinguished Educator Award 2020.